Stem Cell Therapy for Cancer Treatment - As life expectancies increase and lifestyle diseases become more common, preserving stem cells offers valuable insurance against future health challenges.

Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...

Researchers at Moffitt Cancer Center have developed a new tool to predict how cancer cells evolve. By focusing on chromosome ...

The field of colorectal cancer (CRC) research is increasingly focused on understanding how gut microbiota and their metabolites influence therapeutic ...

Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based cancer therapy. Helper T cells act as the immune system’s coordinators, helping ...

An international research team with strong participation from DTU has developed a new biotechnological platform that makes it possible to test and ...

Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells to target tumors. TIL therapy, now FDA-approved for solid tumors, shows ...

Cancer Research Institute, New York, NY, USA. The cancer cell therapy landscape continues to evolve rapidly. In 2024, the first approvals of tumour-infiltrating lymphocyte (TIL) and T cell receptor ...

FEBRUARY 2, 2026, NEW YORK - It is with great pleasure that we announce that the Ludwig Institute for Cancer Research has ...

The company said that outpatient study will evaluate ImmunityBio’s novel, off-the-shelf cell therapy CD19 CAR-NK in ...

Blood Cancer UK, Lymphoma Action and stem cell charity Anthony Nolan have formally appealed against the decision.